Vilar L, Vilar CF, Lyra R, Freitas MDC
Inda C, Armando NG, dos Santos Claro PA, Silberstein S (2017) Endocrinology and the brain: corticotropin-releasing hormone signaling
Published research in animal models has explored Melanotan II in the context of: Mechanism of Action Melanotan II acts as a non-selective agonist at the melanocortin receptors (MC1R, MC3R, MC4R, and MC5R)
Potential side effects include: Gastrointestinal trouble, such as nausea, vomiting, constipation, diarrhea, and abdominal pain Hyperglycemia (low blood sugar), which can lead to blurred vision, sweating, anxiety, dizziness, shakiness, headaches, slurring speech, hunger, or weakness Elevated heart rate Kidney failure Medullary thyroid cancer (also known as medullary thyroid carcinoma) Severe allergic reaction If you experience any severe side effects, inform your healthcare provider immediately